Human normal dermal fibroblasts express somatostatin receptors

Area of Science:

• Endocrinology
• Dermatology
• Molecular Biology

Background:

• Somatostatin (SOM) is a hormone with diverse functions across multiple physiological systems.
• Endogenous SOM exists in 14- and 28-amino acid forms, interacting with five cloned receptor subtypes.
• Somatostatin and its receptors are present in human skin.

Purpose of the Study:

• To investigate the expression and characteristics of somatostatin receptors on normal human dermal fibroblasts.
• To determine the binding affinity and capacity of these receptors for somatostatin and related analogs.
• To evaluate the functional effect of somatostatin on fibroblast DNA synthesis.

Main Methods:

• Human dermal fibroblasts were utilized to study somatostatin receptor expression.
• Biotinyl-SOM was used for receptor visualization, and radioligand binding assays with (3-[125I]iodotyrosyl11)-SOM-14 were performed.
• DNA synthesis was assessed via [3H]-methyl thymidine incorporation, and competitive displacement studies were conducted.

Main Results:

• Saturation and Scatchard analyses revealed a homogeneous class of somatostatin receptors with a Bmax of 0.055 +/- 0.023 nM and KD of 2.0 +/- 0.4 nM.
• Human dermal fibroblasts possess approximately 3,317 +/- 1,385 binding sites per cell.
• Competitive binding assays indicated affinity for SOM-14, SOM-28, and octreotide, suggesting the presence of somatostatin receptor subtype 2 or 3.

Conclusions:

• Human normal dermal fibroblasts express somatostatin receptors, likely subtype 2 or 3.
• These receptors exhibit specific binding affinities for somatostatin and octreotide.
• Somatostatin showed a minimal effect on fibroblast DNA synthesis at the tested concentrations.